NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
Article
Sloan, Andrew E, Winter, Kathryn, Gilbert, Mark R et al. (2024). NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
. NEURO-ONCOLOGY, 26(9), 1628-1637. 10.1093/neuonc/noae058
Sloan, Andrew E, Winter, Kathryn, Gilbert, Mark R et al. (2024). NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
. NEURO-ONCOLOGY, 26(9), 1628-1637. 10.1093/neuonc/noae058